Status:
COMPLETED
Plasma Vitamin and Homocysteine Levels and Thrombosis in Patients With Ph-negative MPNs
Lead Sponsor:
Istanbul University
Conditions:
Thrombosis
Eligibility:
All Genders
18+ years
Brief Summary
Hyperhomocysteinemia is a risk for thrombosis. Thrombosis is more frequent in myeloproliferative neoplasms (MPNs) than the normal population. In this study, we investigated the thrombosis incidence, t...
Detailed Description
Thirty-one new or formerly diagnosed MPN patients who consecutively visitted our outpatient clinic, as well as 40 age and sex matched healthy controls were enrolled in this study.
Eligibility Criteria
Inclusion
- Adult MPN patients and healthy controls who gave a written consent were included in the study.
Exclusion
- Exclusion criteria included not giving a written consent and using medications without an indication which may have an effect on plasma homocysteine and vitamin levels.
Key Trial Info
Start Date :
January 1 2003
Trial Type :
OBSERVATIONAL
End Date :
June 1 2004
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01878916
Start Date
January 1 2003
End Date
June 1 2004
Last Update
June 17 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul University Cerrahpasa Medical Faculty
Istanbul, Turkey (Türkiye)